However, previous investigations have also identified splice variants (SVs) of GHRH-Rs in human cancers and other extrapituitary tissues that can mediate the effects of GHRH and its agonistic and antagonistic analogs [1,4,5,6,7,8,9,10,11] (Figure 1). The gene discussed is GHRH; the disease is cancer.